Fig. 9From: The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey modelMHCSZ-123 inhibited VWF-dependent platelet aggregation. a Ex vivo inhibition of MHCSZ-123 on ristocetin-induced Rhesus monkey platelet aggregation. b Correlation between ex vivo VWF occupancy and inhibition of platelet aggregation induced by ristocetin. Data represent mean ± SD (n = 6 animals per group)Back to article page